MeSH Browser

MeSH Heading: ChAdOx1 nCoV-19
Tree Number(s): D20.215.894.865.450.250.500; D20.215.894.899.085.063
Unique ID: D000090985
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000090985
Scope Note: A viral vector vaccine against SARS-CoV-2 developed by AstraZeneca. Its vector encodes the SARS-CoV-2 Spike protein.
Entry Term(s): AZD-1222; AZD1222; COVID-19 Vaccine AstraZeneca; ChAdOx1 COVID-19 Vaccine; Covishield; Oxford-AstraZeneca COVID Vaccine; Oxford-AstraZeneca COVID-19 Vaccine; Vaxzevria
Registry Number: B5S3K2V0G8
Public MeSH Note: 2022; ChAdOx1 nCoV-19 VACCINE was indexed under COVID-19 VACCINES 2021
History Note: 2022(2021)
Date Established: 2022/01/01
Date of Entry: 2021/07/09
Revision Date: 2022/04/14

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

antagonists & inhibitors (AI)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M000747632
Registry Number: B5S3K2V0G8
Scope Note: A viral vector vaccine against SARS-CoV-2 developed by AstraZeneca. Its vector encodes the SARS-CoV-2 Spike protein.
Terms: ChAdOx1 nCoV-19 Preferred Term
Term UI T001107365
Date06/01/2021
LexicalTag NON
ThesaurusID NLM (2022); COVID-19 Vaccine AstraZeneca
Term UI T001105741
Date04/30/2021
LexicalTag NON
ThesaurusID NLM (2022); ChAdOx1 COVID-19 Vaccine
Term UI T001105747
Date04/30/2021
LexicalTag NON
ThesaurusID NLM (2022); Oxford-AstraZeneca COVID Vaccine
Term UI T001115268
Date12/02/2021
LexicalTag NON
ThesaurusID NLM (2022); Oxford-AstraZeneca COVID-19 Vaccine
Term UI T001115269
Date12/02/2021
LexicalTag NON
ThesaurusID NLM (2022)

ChAdOx1 nCoV-19 MeSH Descriptor Data 2023